Ann: TGA Approval Granted For ZolpiMist, page-102

Hi Beale and Dpowell

At $900 or even $100 Zolpimist will always be a niche market but at $40-60 Zolpimist would be well suited to the retail volume market. That is assuming those walkers at WHO decide to ban it for the same ridulous reason that they did not approve ArTiMist. I suppose a jar or tablets containing 100 pills could be banned for the same reason.
?

However I digress and after checking the SUDA ASX Ann's on 12 May and 29 July it is confirmed that SUDA will be engaging an experienced generic manufacturer and presumably SUAD will set the retail price and in due course pass a royalty back to Aytu which I hope is based on a % of retail sales.

I have also wondered if SUDA have plans to try to have Zolpimist accepted onto the PBS (Pharmaceutical Benefirs Scheme)
Mind you, with some State Govts due to go to the polls this year who needs sleeping pills or sprays.... 5mins of listening to a politician will do the same job.

kippax